{"id":28472,"date":"2024-11-12T15:42:08","date_gmt":"2024-11-12T14:42:08","guid":{"rendered":"https:\/\/ggba.swiss\/?p=28472"},"modified":"2024-11-12T15:42:10","modified_gmt":"2024-11-12T14:42:10","slug":"lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/","title":{"rendered":"Lonza expands bioconjugation capacity in Visp and creates 300 jobs"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.lonza.com\/\">Lonza<\/a> is set to strengthen its position as a global leader in bioconjugation with two major expansion initiatives at its Ibex\u00ae Biopark in Visp, in the canton of Valais. The expansions, announced in <a href=\"https:\/\/www.lonza.com\/news\/2024-10-22-07-00\">October<\/a> and <a href=\"https:\/\/www.lonza.com\/news\/2024-11-12-07-00\">November<\/a> 2024, are aimed at bolstering Lonza\u2019s production capabilities to meet rising market demand for antibody-drug conjugates (ADCs) and other bioconjugates used in cancer therapies.<\/p>\n\n\n\n<p>The first announcement detailed Lonza\u2019s extended partnership with a major biopharmaceutical company for the large-scale manufacture of ADCs. This agreement includes constructing a new customer-dedicated bioconjugation suite, with around 800 square meters of manufacturing space, set to be operational by 2027. This facility will handle highly potent modalities for ADC production, generating approximately 100 new jobs in Visp. The biopharmaceutical partner selected Lonza\u2019s end-to-end solution, which includes monoclonal antibody (mAb) production at Lonza\u2019s Porri\u00f1o site in Spain, followed by bioconjugation at the Visp facility.<\/p>\n\n\n\n<p>Shortly after, Lonza announced a further expansion of its Visp facilities to add two multipurpose bioconjugation suites. Occupying 2,000 square meters, these suites will provide additional manufacturing capacity for both clinical and commercial bioconjugate supplies. Designed to support complex processes and multiple customers, these suites are anticipated to open in 2028, creating 200 new jobs. This latest investment will double Lonza\u2019s multipurpose production capabilities, addressing the increased demand for bioconjugates as ADCs advance toward commercialization.<\/p>\n\n\n\n<p>Lonza\u2019s expanded capacity aims to support a broader customer base while streamlining production for drugs advancing through various phases of development. Sustainability is integral to the new designs, incorporating energy-efficient systems and innovative waste management technologies to reduce waste by up to 90%. &#8220;With these expansions, we address a critical market need and reinforce our ability to deliver flexible, scalable solutions,\u201d commented Christian Morello, Vice President and Head of Bioconjugates at Lonza.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lonza strengthens its bioconjugation capabilities in Visp with two major expansions, adding three new suites and creating 300 jobs to meet growing demand.<\/p>\n","protected":false},"author":6,"featured_media":28473,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,918,911,885],"class_list":["post-28472","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-investment","tag-pharma","tag-vaccines"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lonza expands bioconjugation capacity and creates 300 jobs<\/title>\n<meta name=\"description\" content=\"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lonza expands bioconjugation capacity and creates 300 jobs\" \/>\n<meta property=\"og:description\" content=\"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-12T14:42:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-12T14:42:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Lonza expands bioconjugation capacity in Visp and creates 300 jobs\",\"datePublished\":\"2024-11-12T14:42:08+00:00\",\"dateModified\":\"2024-11-12T14:42:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\"},\"wordCount\":299,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Investment\",\"Pharma\",\"Vaccines\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\",\"url\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\",\"name\":\"Lonza expands bioconjugation capacity and creates 300 jobs\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg\",\"datePublished\":\"2024-11-12T14:42:08+00:00\",\"dateModified\":\"2024-11-12T14:42:10+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"An aerial view of Lonza\u2019s Ibex\u00ae Biopark in Visp, where new bioconjugation suites are being built to expand production capabilities. | \u00a9 Lonza\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lonza expands bioconjugation capacity in Visp and creates 300 jobs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lonza expands bioconjugation capacity and creates 300 jobs","description":"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/","og_locale":"en_US","og_type":"article","og_title":"Lonza expands bioconjugation capacity and creates 300 jobs","og_description":"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.","og_url":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-11-12T14:42:08+00:00","article_modified_time":"2024-11-12T14:42:10+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Lonza expands bioconjugation capacity in Visp and creates 300 jobs","datePublished":"2024-11-12T14:42:08+00:00","dateModified":"2024-11-12T14:42:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/"},"wordCount":299,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg","keywords":["Biotech","Investment","Pharma","Vaccines"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/","url":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/","name":"Lonza expands bioconjugation capacity and creates 300 jobs","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg","datePublished":"2024-11-12T14:42:08+00:00","dateModified":"2024-11-12T14:42:10+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Lonza strengthens its bioconjugation capabilities in Visp, adding three new suites and creating 300 jobs to meet growing demand.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/11\/Lonza-300-Jobs-2024-VS-1180x811-1.jpg","width":1180,"height":811,"caption":"An aerial view of Lonza\u2019s Ibex\u00ae Biopark in Visp, where new bioconjugation suites are being built to expand production capabilities. | \u00a9 Lonza"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/lonza-expands-bioconjugation-capacity-in-visp-and-creates-300-jobs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Lonza expands bioconjugation capacity in Visp and creates 300 jobs"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=28472"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28472\/revisions"}],"predecessor-version":[{"id":28476,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/28472\/revisions\/28476"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/28473"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=28472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=28472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=28472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}